MADRS: Difference between revisions

MADRS (view source)

Revision as of 23:24, 16 October 2023

321 bytes removed , 23:24, 16 October 2023

m

no edit summary

WikiSysop

Bureaucrats, Interface administrators, Administrators

2,865

edits

@@ Line 12: / Line 12: @@
 * Suicidal thoughts
-Each item yields a score of 0 to 6; the overall score thus ranges from 0 to 60. One of the largest psychedlic (psilocybin) studies has found that a 2.5mg dose can lead to a 6.6 point reduction in MADRS score<ref>'''COMPASS Pathways announces positive topline results from groundbreaking phase IIb trial of investigational COMP360 psilocybin therapy for treatment-resistant depression.''' November 09, 2021. Accessed on 17th October 2023 via: https://ir.compasspathways.com/news-releases/news-release-details/compass-pathways-announces-positive-topline-results</ref>.
+Each item yields a score of 0 to 6; the overall score thus ranges from 0 to 60. One of the largest psychedelic ([[psilocybin]]) studies has found that a 2.5mg dose can lead to a 6.6 point reduction in MADRS score<ref>'''COMPASS Pathways announces positive topline results from groundbreaking phase IIb trial of investigational COMP360 psilocybin therapy for treatment-resistant depression.''' November 09, 2021. Accessed on 17th October 2023 via: https://ir.compasspathways.com/news-releases/news-release-details/compass-pathways-announces-positive-topline-results</ref>.
-=== Psychedelic Therapy and Depression ===
-Psychedelic therapy refers to the therapeutic use of psychedelics, like psilocybin or MDMA, often in conjunction with psychotherapy. This therapy has gained interest in recent years for its potential efficacy in treating a variety of mental health disorders, especially depression.
 === Role of MADRS in Psychedelic Therapy ===

MADRS (view source)

Revision as of 23:24, 16 October 2023

Share your opinion